Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
מצבים רפואיים
Breast Cancer · Breast Cancer Metastatic · Hormone Receptor Positive Tumor · Human Epidermal Growth Factor 2 Negative Carcinoma of Breast · Ovarian Cancer · CCNE1 Amplification · Solid Tumor · Advanced Cancer · Metastatic Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Florida Cancer Specialists, Orlando, Florida, United States
Contact: Principal Investigator (Cesar Perez, MD)Emory Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Principal Investigator (Kevin M Kalinsky, MD)Georgia Cancer Center at Augusta University, Augusta, Georgia, United States
Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, United States
Contact: Principal Investigator (Sunil Babu, MD)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Antonio Giordano, MD)Karmanos Cancer Institute, Detroit, Michigan, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Contact: Principal Investigator (Sheheryar Kabraji, MD)Levine Cancer Institute (LCI)- Atrium Health, Charlotte, North Carolina, United States
Contact: Principal Investigator (Antoinette Tan, MD)Duke Cancer Center/ DUMC, Durham, North Carolina, United States
Contact: Principal Investigator (Carey Anders, MD)Gabrail Cancer Research Center, Canton, Ohio, United States
Contact: Principal Investigator (Nashat Gabrail, MD)Next Oncology, Dallas, Texas, United States
Contact: Principal Investigator (Michael Song, MD)UTSW Medical Center, Dallas, Texas, United States
Contact: Principal Investigator (David Miller, MD)Oncology Consultants, Houston, Texas, United States
Contact: Principal Investigator (Julio Peguero, MD)Next Oncology, Houston, Texas, United States
Contact: Principal Investigator (Jennifer Segar, MD)Northwest Medical Specialties, PLLC, Tacoma, Washington, United States
Contact: Principal Investigator (Jorge Chaves, MD)Peninsula and South Eastern Haematology & Oncology Group, Frankston, Victoria, Australia
Contact: Principal Investigator (Vinod Ganju, MD)Peter MacCallum Cancer Center, Parkville, Victoria, Australia
Contact: Principal Investigator (George Au-Yeung, MD)Mater Hospital, South Brisbane, Australia
Contact: Principal Investigator (Catherine Shannon, MD)